If you're looking for a quick and easy way to build a diverse portfolio, then exchange traded funds (ETFs) could be the answer.
That's because ETFs give investors the opportunity to invest in a large number of shares through just a single investment. In some cases, this provides instant diversification for a portfolio.
With that in mind, listed below are three ETFs that could be excellent options for investors next week. Here's what you need to know about them:
BetaShares Global Energy Companies ETF (ASX: FUEL)
With oil prices trading in or around the US$90 per barrel level, energy producers are printing money at present. This bodes well for the companies included in the BetaShares Global Energy Companies ETF. This includes the leading players in the energy sector such as BP, Chevron, ExxonMobil, and Royal Dutch Shell. And with OPEC intent on not letting prices weaken, the coming years look positive for these companies and the ETF.
Vanguard Australian Shares Index ETF (ASX: VAS)
Another ETF for investors to look at next week is the Vanguard Australian Shares Index ETF. It provides investors with easy access to 300 of the largest companies on the Australian share market. This means you'll be buying a highly diverse group of shares from a multitude of sectors. This includes miners such as BHP Group Ltd (ASX: BHP), banks like Commonwealth Bank of Australia (ASX: CBA), and retail giants including Woolworths Group Ltd (ASX: WOW). Another positive with the ETF is that it pays a decent dividend. At the last count, it was offering a trailing yield of ~7%.
Vanguard MSCI Index International Shares ETF (ASX: VGS)
A final ETF for investors to consider buying next week is the Vanguard MSCI Index International Shares ETF. This is arguably the most diverse ETF available today. That's because the Vanguard MSCI Index International Shares ETF allows investors to buy a slice of approximately ~1,500 of the world's largest listed companies. This means you'll be owning many of the world's biggest and best-known companies such as Amazon, Apple, AstraZeneca, Johnson & Johnson, JP Morgan, Nestle, Procter & Gamble, and Visa.
